Tonix Pharmaceuticals has launched Tonmya (cyclobenzaprine), a newly approved oral treatment for adults with fibromyalgia.

Credit: Tonix Pharmaceuticals. Tonmya is a once-daily sublingual tablet of cyclobenzaprine HCI taken at bedtime for the treatment of fibromyalgia. Clinical trials have demonstrated that Tonmya reduces ...

TNXP READ THE FULL TNXP RESEARCH REPORT Business Update Tonmya™ Commercial Launch Underway Following the approval of Tonmya™ ...

Here’s what to look for in a fibromyalgia care provider to ensure you get the most compassionate, collaborative treatment.

Discover the National Fibromyalgia Association's mission to enhance life for people with fibromyalgia through awareness, education, support, and advocacy efforts.

Investing.com -- Tonix Pharmaceuticals (NASDAQ:TNXP) stock rose 8% after the company announced that its first-in-class fibromyalgia treatment TONMYA is now commercially available by prescription in ...

Researchers and patients are calling for the NHS to overhaul its care of fibromyalgia patients.

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Research suggests that the nerve injury itself is to blame. Itch-sensing nerves, much like pain-sensing ones, can go haywire and begin sending excessive or inappropriate signals. This may happen when ...

Australian scientists have identified the key genetic drivers behind long COVID, revealing why some people continue to experience debilitating symptoms long after their initial infection. The ...

Ms. Ishak brings more than 25 years of corporate legal and strategic leadership experience in the life sciences industry ...